Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study.

BMC Endocr Disord · 2016 · PMC4899904 · PMID 27278922

Europe PMC DOI

hedged sentence

0.1220

closest p · 2.4× alpha

0.1220

boldest claim

The sentences

did not reach statistical significanceP = 0.122not close (p > 0.1)

Although BIAsp 30 decreased FPG and PPG concentrations to a larger extent, the difference did not reach statistical significance (132.00 ± 13.2 vs. 144.33 ± 8.16, P = 0.122).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.